-
Non-Small Cell Lung Cancer Market: Valued at $18.8 Billion in 2024, Expected to Grow at 6.9% CAGR Through 2035
15 Jul 2025 07:59 GMT
… squamous non-small cell lung cancer, metastatic colorectal cancer … Non-Small Cell Lung Cancer Market by Type
• Adenocarcinomas
• … Others
Global Non-Small Cell Lung Cancer Market by Therapy
• …
Global Non-Small Cell Lung Cancer Market by End-User …
-
MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non─small cell lung cancer
11 Jul 2025 06:35 GMT
… opportunity: Non-small cell lung cancer represents one of the largest … by induction of cancer type–specific immune memory. Ateganosine … for non-small cell lung cancer for patients that have … advanced non-small cell lung cancer patients receiving third line …
-
FDA OKs New Test to Match Lung Cancer Patients With Targeted Therapies
10 Jul 2025 22:57 GMT
… test for patients with lung cancer to match the correct … patients with non-small cell lung cancer (NSCLC) whose disease harbor … -generation sequencing is a type of technology that is used … mutations, a difficult-to-treat lung cancer subtype,” said Susan Chen, …
-
Baseline Steroid Use Linked to Poorer Outcomes in ICI-Treated Lung Cancer
10 Jul 2025 16:56 GMT
… with non–small cell lung cancer (NSCLC) treated with … most common type of lung cancer, about 87% of all lung cancers, according … .
Non–small cell lung cancer is often treated with … frequently prescribed to manage lung cancer symptoms. Although steroid …
-
SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model and its catalytic activity is regulated by histone acetylation
09 Jul 2025 18:24 GMT
… KRAS mutation in this tumor type, and identify potential regulatory roles … .SETD2 ablation promotes KRASG12C-driven lung tumorigenesis in vivo.
A, Schematic of … 21 cancer types (48). Consistent with these observations and previous lung cancer mouse …
-
Nomogram for Predicting Postoperative Cardiopulmonary Complications in Non-Small Cell Lung Cancer Based on Systemic Inflammatory Markers: A Retrospective Study
09 Jul 2025 13:50 GMT
…
Lung cancer is the most prevalent and deadly type … treatment for lung cancer.3 However, following lung cancer surgery, … cardiopulmonary complications in lung cancer include pulmonary function … cardiopulmonary complications in lung cancer mainly include …
-
Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines
09 Jul 2025 12:30 GMT
… -dependent inhibition in lung cancer cells harboring KRAS … around 30% of lung cancers. Lung cancer represents a particularly … multiple challenging cancer types characterized by historically … in colorectal and lung cancer applications, potential expansion …
-
New study reveals that Epstein–Barr virus infection may increase riskof a broad spectrum of cancer types
11 Jul 2025 12:47 GMT
… of developing cancers such as lung cancer, liver cancer, nasopharyngeal carcinoma, … developing specific cancer types among seropositive individuals. For lung cancer, individuals with EBV … EBV infection with certain cancer types, such as lymphomas and …
-
AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment
03 Jul 2025 17:06 GMT
… AstraZeneca the rights to a lung cancer drug called ivonescimab.
Bloomberg reported … Read: Summit Therapeutics’ Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall … BNT327, across various solid tumor types.
Price Action: Summit Therapeutics shares …
-
In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®
14 Jul 2025 14:00 GMT
… as breast cancer (HER2 testing), lung cancer (ALK/ROS1 rearrangements), and … Farms, Livestock Farms), By Product Type (Chemical Treatments, Biological Treatments), By …
About
© 1995-2025